After months of legal battles over the felony drug charges against the former chief medical officer of Vireo Health, Dr. Laura Bultman, and Vireo’s downtown White Plains dispensary, has been upheld.
A Court of Appeals in Minnesota upheld the charges rejecting the officers’ bid to toss the charges. The appellate decision means that a trial is more likely now.
The two ex-Vireo senior execs were accused of smuggling medical marijuana from Minnesota to New York. The accusations note that the two used the firm’s armored automobile to move medicated cannabis oil between two states illegally.
After reviewing the case as to whether the laws addressed the smuggling of medical pot across the two-state borders well enough, the court ruled that the law didn’t allow the transfer.
The Legal Argument
According to the Minnesota regulations, the apparent smuggling case turns out to point out various legal arguments. For instance, the first argument could be either that some criminals desperately smuggled the medical cannabis in the armored SUV packed with almost $500,000 of cannabis oil.
The other scenario is that maybe respected corporate officers would have transported (behind the masks) the state-licensed medical cannabis from the Minnesota-based company to the affiliate in New York.
Some aspects of the case also have few other connections to the New York State’s medical cannabis program, like allegations that the cannabis oil was illegally sold to patients which were later tested at the state government’s Wadsworth Lab.
The Department of Health in New York, which oversees the cannabis program, reported that it was independently investigating the smuggling allegations and said to release the findings when the case concludes.
The alleged smuggling could indeed be illegal according to the Appellate Court. The two officers are charged with transferring medical cannabis to some unauthorized person.
Nevertheless, the case has implications for the growing cannabis industry in Minnesota and New York. Perhaps, it has exposed some potential holes in the efforts the government is putting into preventing medical cannabis from crossing the state borders. These scenarios increase the threat of the federal Drug Enforcement Administration raids on the companies licensed by the state laws.
For the latest marijuana industry news updates and the hottest MJ stocks, sign up below!
Why Buy From Marijuana Seed Banks?
If you’re interested in growing marijuana and live in a state that allows its cultivation, then you might want to consider buying seeds from seed banks. Some of the best cannabis get cultivated outside the country, which means that, sometimes, you have to find a seed bank that ships to the US.
There are a lot of options when it comes to sources for marijuana seeds online. However, not all of them can ship to the US due to strict regulations in the country. Thus, it’s best to find a legit seed bank that can process orders from United States customers.
Avoid transacting with other sources aside from seed banks. If you do so, you run the risk of receiving low-quality products, wasting your money in the end. Look for a company with positive feedback and has a proven history of dealing with US customers. Some of the most popular ones include Seedsman and I Love Growing Marijuana (IGLM). You can check out GreenBudGuru’s Seedsman review and their review of other companies to find the best fit for your needs.
If you’re looking to get your seeds online, below are some reasons you should buy marijuana seeds from a trusted and reliable marijuana seed banks.
You Don’t Have Any Other Option
As mentioned above, some states in the US still don’t allow local buying and selling of marijuana, even if medical marijuana consumption has already gained momentum. If…
22nd Century Group Inc (NYSE:XXII): 3 Reasons You May Want To Buy The Stock This Month
The tobacco industry is huge and growing. The cannabis industry is already booming yet it is only in the early stages of development and the future looks incredibly bright as more countries legalize pot. 22nd Century Group Inc (NYSE:XXII) is the stock that offers investors the chance to own the best of both tobacco and cannabis worlds.
The stock currently trades at $1.00/share. But that is not where it belongs as that is its lowest watermark. As recently as September, NYSE:XXII was trading above $2.40/share.
For investors who may have just come across 22nd Century Group for the very first time, here is a brief profile of the company. 22nd Century Group is a plant biotechnology company and a leader in tobacco harm reduction. It has also set its sight on the legal hemp and cannabis industries. In the tobacco space, NYSE:XXII has developed a low-nicotine tobacco plant variety. In the hemp/cannabis space, the company is working to develop hemp and cannabis plants with specific desirable qualities.
If you are looking to have a footing in both tobacco and cannabis industries, here are three reasons you may want to buy NYSE:XXII.
- 22nd Century Group on track to take control of CBD products maker Panacea Life Sciences
On December 3, 22nd Century…
Green Organic Dutchman Holdings Ltd (OTCMKTS:TGODF) Tumbles 90%: What’s Behind The Dive?
A nearly 90% pullback from its all-time highs has brought Green Organic Dutchman Holdings Ltd (OTCMKTS:TGODF) down to its record lows. The selloff in TGODF comes as Canada’s regulated cannabis industry struggles with a number of headwinds.
First, Canadian authorities aren’t approving the opening of new cannabis retail outlets fast enough. For instance, in Ontario, Canada’s most populous province with a population of more than 14 million people, there are just 24 cannabis shops. That means that while there is demand for cannabis in Canada, the shortage of shops, getting the products to customers remains a major challenge. In turn, that limits sales for cannabis producers like TGODF.
In addition to the shortage of cannabis shops, black market is another headwind that Canada’s regulated cannabis businesses like TGODF have run into. Experts estimates that black market accounts for 86% of cannabis sales in Canada, thereby chocking the regulated market.
In response to the sluggish development of Canada’s regulated cannabis market, which is caused by shortage of cannabis shops, TGODF has decided to slow down investment in its production capacity expansion.
Slowing down capacity expansion will see TGODF cut back on spending. In turn, the company expects this move and other actions in plans to take will reduce its cash burn and set it firmly on the path to profitability in the near-term.…